Pharmaceuticals News and Research

RSS

IAS conference opens with push for treatment as prevention

The 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention taking place in Rome this week "started optimistically as the hype surrounding the use of antiretroviral treatment to prevent HIV infection gained momentum. But the focus of much discussion … will undoubtedly be on how to transform the recent promising research findings into workable policy," PlusNews reports.

20 Jul 2011

New report: Global cardiac catheters market to reach US$2.1B by 2015

The global cardiac catheters market is forecast to reach US$2.1 billion by 2015 at a CAGR of 12.9% during the analysis period 2009-2015, according to a new report available on companiesandmarkets.com.

20 Jul 2011

New insights into sleep difficulties among older people

A new study of the brain's master circadian clock - known as the suprachiasmatic nucleus, or SCN - reveals that a key pattern of rhythmic neural activity begins to decline by middle age. The study, whose senior author is UCLA Chancellor Gene Block, may have implications for the large number of older people who have difficulty sleeping and adjusting to time changes.

20 Jul 2011

New transgenic mouse could predict toxicity of targeted cancer drugs

Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product. The majority of new agents are only shown to be unsuitable in the later phases of clinical development which would explain the exorbitantly high development costs of 500 to 600 million euros per new cancer drug.

20 Jul 2011

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration for VELCADE® (bortezomib) for injection to add overall survival data after a five-year follow up to the product label.

20 Jul 2011

Valeant, sanofi-aventis partner to market and distribute Zuacta cream

Valeant Pharmaceuticals International, Inc. announced today that its subsidiary, Valeant International SRL, has entered into an agreement with sanofi-aventis Canada Inc.

20 Jul 2011

CEL-SCI expands licensing agreement with Teva for Multikine cancer drug

CEL-SCI Corporation announced today that it has expanded the licensing agreement with Teva Pharmaceutical Industries Ltd. for its cancer drug Multikine.

20 Jul 2011

Bound Tree acquires Alliance Medical

Bound Tree Medical, the nation's leading provider of emergency medical supplies and equipment to the pre-hospital market, today announced that it has acquired Alliance Medical, Inc.

19 Jul 2011

New nanotechnology-based cancer treatment might improve chemotherapy

Researchers of the University of Granada and Edinburgh have developed a new therapy for cancer based on nanotechnology that might improve significantly chemotherapy, as it has not cause side effects.

19 Jul 2011

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Johnson & Johnson today announced sales of $16.6 billion for the second quarter of 2011, an increase of 8.3% as compared to the second quarter of 2010.

19 Jul 2011

EPA to expand Cooperative Research And Development Agreement with NanoLogix

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.

19 Jul 2011

DNDi's new drug development programme for children with HIV/AIDS

Today at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, the Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV/AIDS.

19 Jul 2011

UNAIDS' Sidibe calls for increased access to HIV drugs at IAS conference opening

UNAIDS Executive Director Michel Sidibe on Sunday at the opening of the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome "called ... for an increase in access to drugs that help treat or prevent the spread of the disease, saying it is 'morally wrong' to keep millions of people off lifesaving medication," the Associated Press/Boston Globe reports.

19 Jul 2011

A*Star Institute of Microelectronics shortens drug development cycle with new silicon-based screening tool

Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.

19 Jul 2011

Cegedim, Hitachi partner to offer Customer Relationship Management solutions

Hitachi, Ltd. and Cegedim Relationship Management today announced a formal strategic partnership to offer Customer Relationship Management (CRM) solutions to Life Sciences companies in the Asia Pacific region.

19 Jul 2011

Convergence initiates CNV1014802 Phase II study in lumbosacral radiculopathy

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the Phase II proof of concept study with CNV1014802 for treating pain associated with lumbosacral radiculopathy (LSR) has started.

19 Jul 2011

Catylix, Illinois enter license agreement to incorporate fluorine into drugs

Catylix, Inc. and the University of Illinois at Urbana-Champaign have entered into a license agreement under which Catylix will utilize a technology developed by Illinois' Professor John Hartwig to quickly and efficiently introduce fluorine and fluorine-containing substituents into molecules.

19 Jul 2011

IMD, BioFocus enter marketing collaboration to offer enhanced natural product discovery

BioFocus, an integrated drug discovery service partner, and InterMed Discovery GmbH (IMD), a natural product lead-discovery company, today announced a marketing collaboration to offer enhanced natural product discovery to the pharmaceutical, animal health, and agrochemical industries. No financial details were disclosed.

19 Jul 2011

Sherpa opens new CGMP production facility in San Diego

Sherpa Clinical Packaging, a privately held provider of Clinical Trial Material management services, hosted a ribbon cutting ceremony today to mark the opening of its newly constructed state-of-the-art, CGMP production facility in San Diego, CA.

19 Jul 2011

International Journal of Cancer publishes Bionovo's Bezielle research

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the publication of a study of the metabolic effects of its drug candidate, Bezielle, on cancer cells in the International Journal of Cancer.

19 Jul 2011